These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 14458180)

  • 21. An unusual intramolecular hetero-Diels-Alder cycloaddition.
    Stoner EJ; Allen MS; Christesen AC; Henry RF; Hollis LS; Keyes R; Marsden I; Rehm TC; Shiroor SG; Soni NB; Stewart KD
    J Org Chem; 2005 Apr; 70(8):3332-5. PubMed ID: 15823010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physico-chemical properties and biological activities of erythromycin nalidixate.
    Goswami BB; Manna PK; Basu SK
    Arzneimittelforschung; 1995 Jul; 45(7):813-4. PubMed ID: 8573228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel fluorinated erythromycin antibiotic.
    Goss RJ; Hong H
    Chem Commun (Camb); 2005 Aug; (31):3983-5. PubMed ID: 16075093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlled release microspheres based on Eudragit L100 for the oral administration of erythromycin.
    Morishita I; Morishita M; Machida Y; Nagai T
    Drug Des Deliv; 1991 Jul; 7(4):309-19. PubMed ID: 1930622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Kinetic and equilibrium parameters of erythromycin sorption on various sorbents].
    Kotova NV
    Antibiot Khimioter; 2009; 54(11-12):3-6. PubMed ID: 20583559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Studies on conditions for paper chromatography of erythromycin].
    PIECHOWSKA M; OSTROWSKA-KRYSIAK B
    Med Dosw Mikrobiol; 1961; 13():167-72. PubMed ID: 13735502
    [No Abstract]   [Full Text] [Related]  

  • 27. Electronic structure of antibiotic erythromycin.
    Novak I; Kovač B
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Mar; 138():550-2. PubMed ID: 25528514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Encapsulation of hydrophobic drugs in Pluronic F127 micelles: effects of drug hydrophobicity, solution temperature, and pH.
    Basak R; Bandyopadhyay R
    Langmuir; 2013 Apr; 29(13):4350-6. PubMed ID: 23472840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solid-state investigations of erythromycin A dihydrate: structure, NMR spectroscopy, and hygroscopicity.
    Stephenson GA; Stowell JG; Toma PH; Pfeiffer RR; Byrn SR
    J Pharm Sci; 1997 Nov; 86(11):1239-44. PubMed ID: 9383733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Resistance of 6-aminopenicillic acid in aqueous solutions].
    KONDRAT'EVA AP; DRUZHININA EN; BRUNS BP; NIKOLAEVA TA
    Antibiotiki; 1962 May; 7():442-8. PubMed ID: 14458181
    [No Abstract]   [Full Text] [Related]  

  • 31. Structure and function of the macrolide biosensor protein, MphR(A), with and without erythromycin.
    Zheng J; Sagar V; Smolinsky A; Bourke C; LaRonde-LeBlanc N; Cropp TA
    J Mol Biol; 2009 Apr; 387(5):1250-60. PubMed ID: 19265703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase transformation of erythromycin A dihydrate during fluid bed drying.
    Römer M; Heinämäki J; Miroshnyk I; Kivikero N; Sandler N; Rantanen J; Yliruusi J
    J Pharm Sci; 2008 Sep; 97(9):4020-9. PubMed ID: 18200525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dermatologic preparations with erythromycin--the correlation of the pharmaceutical form-therapeutic effect].
    Cojocaru I; Irimia O; Constantin T
    Rev Med Chir Soc Med Nat Iasi; 1997; 101(3-4):166-9. PubMed ID: 10756791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Biogenesis and regulation of biosynthesis of erythromycins in Saccharopolyspora erythraea: a review].
    Mironov VA; Sergienko OV; Nastasiak IN; Danilenko VN
    Prikl Biokhim Mikrobiol; 2004; 40(6):613-24. PubMed ID: 15609849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and evaluation of stable and taste-free erythromycin proprodrugs.
    Bhadra PK; Morris GA; Barber J
    J Med Chem; 2005 Jun; 48(11):3878-84. PubMed ID: 15916440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of erythromycin A oxime and its related compounds by RP-HPLC on base-deactivated column].
    Cao Z; Liang J; Yao G; Yang X
    Se Pu; 2007 Nov; 25(6):946-7. PubMed ID: 18257324
    [No Abstract]   [Full Text] [Related]  

  • 37. The post-antibiotic effects of rokitamycin (a 16-membered ring macrolide) on susceptible and erythromycin-resistant strains of Streptococcus pyogenes.
    Braga PC; Culici M; Dal Sasso M
    Int J Antimicrob Agents; 2004 Sep; 24(3):254-60. PubMed ID: 15325429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catalytic site-selective synthesis and evaluation of a series of erythromycin analogs.
    Lewis CA; Merkel J; Miller SJ
    Bioorg Med Chem Lett; 2008 Nov; 18(22):6007-11. PubMed ID: 18819795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rokitamycin: bacterial resistance to a 16-membered ring macrolide differs from that to 14- and 15-membered ring macrolides.
    Braga PC
    J Chemother; 2002 Apr; 14(2):115-31. PubMed ID: 12017366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Resistance of certain N-glucoside peptides and N-glucoside proline in aqueous solutions].
    KALIS VE; KAVERZNEVA ED
    Biokhimiia; 1959; 24():1026-32. PubMed ID: 14404119
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.